Literature DB >> 34893932

Spherical Agglomerates of Lactose Reduce Segregation in Powder Blends and Improve Uniformity of Tablet Content at High Drug Loads.

Dejan Lamešić1,2, Blaž Grilc3, Robert Roškar3, Selina Kolokytha4, Jürgen Hofmann4, Andreas Malekos4, Rolf Kaufmann4, Odon Planinšek3.   

Abstract

We report here on improved uniformity of blends of micronised active pharmaceutical ingredients (APIs) using addition of spherical agglomerates of lactose and enhanced blend flow to improve tablet content uniformity with higher API loads. Micromeritic properties and intra-particle porosity (using nano-computed X-ray tomography) of recently introduced spherical agglomerates of lactose and two standard lactose grades for the direct compression processes were compared. Powder blends of the individual lactose types and different micronised API drug loads were prepared and subjected to specific conditions that can induce API segregation. Tablet content uniformity during direct compression was related to the lactose material attributes. The distinctive micromeritic properties of the lactose types showed that spherical agglomerates of lactose had high intra-particle porosity and increased specific surface area. The stability of binary blends after intense sieving was governed by the intra-particle porosity and surface roughness of the lactose particles, which determined the retention of the model substance. Greater intra-particle porosity, powder specific surface area, and particle size of the spherical agglomerates provided greater adhesion of micronised particles, compared to granulated and spray-dried lactose. Thus the spherical agglomerates provided enhanced final blend flow and uniformity of tablet content at higher drug loads.
© 2021. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  direct compression; lactose; nano-computed x-ray tomography; segregation; spherical agglomerates

Mesh:

Substances:

Year:  2021        PMID: 34893932     DOI: 10.1208/s12249-021-02150-3

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  18 in total

1.  Magnetic resonance imaging investigation of the mixing-segregation process in a pharmaceutical blender.

Authors:  N Sommier; P Porion; P Evesque; B Leclerc; P Tchoreloff; G Couarraze
Journal:  Int J Pharm       Date:  2001-07-17       Impact factor: 5.875

2.  An engineering view of pharmaceutical powder mixing.

Authors: 
Journal:  Pharm Sci Technol Today       Date:  2000-09-01

3.  The manufacture of low-dose oral solid dosage form to support early clinical studies using an automated micro-filing system.

Authors:  Mingda Bi; Changquan Calvin Sun; Francisco Alvarez; Fernando Alvarez-Nunez
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

4.  The influence of direct compression powder blend transfer method from the container to the tablet press on product critical quality attributes: a case study.

Authors:  Michał Teżyk; Emilia Jakubowska; Kasylda Milczewska; Bartłomiej Milanowski; Adam Voelkel; Janina Lulek
Journal:  Drug Dev Ind Pharm       Date:  2017-01-17       Impact factor: 3.225

5.  Monitoring blending of pharmaceutical powders with multipoint NIR spectroscopy.

Authors:  Otto Scheibelhofer; Nikolaus Balak; Patrick R Wahl; Daniel M Koller; Benjamin J Glasser; Johannes G Khinast
Journal:  AAPS PharmSciTech       Date:  2012-12-21       Impact factor: 3.246

6.  Visualization and quantitative profiling of mixing and segregation of granules using synchrotron radiation X-ray microtomography and three dimensional reconstruction.

Authors:  Ruihao Liu; Xianzhen Yin; Haiyan Li; Qun Shao; Peter York; You He; Tiqiao Xiao; Jiwen Zhang
Journal:  Int J Pharm       Date:  2013-02-10       Impact factor: 5.875

Review 7.  A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms.

Authors:  Michael Leane; Kendal Pitt; Gavin Reynolds
Journal:  Pharm Dev Technol       Date:  2014-08-27       Impact factor: 3.133

8.  Determination of the scale of segregation of low dose tablets using hyperspectral imaging.

Authors:  David R Ely; M Teresa Carvajal
Journal:  Int J Pharm       Date:  2011-05-12       Impact factor: 5.875

9.  Quality-by-design (QbD): effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester.

Authors:  Lin Xie; Huiquan Wu; Meiyu Shen; Larry L Augsburger; Robbe C Lyon; Mansoor A Khan; Ajaz S Hussain; Stephen W Hoag
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

10.  Surface engineered excipients: III. Facilitating direct compaction tableting of binary blends containing fine cohesive poorly-compactable APIs.

Authors:  Liang Chen; Zizhou He; Kuriakose T Kunnath; Siqi Fan; Yuhan Wei; Xiaoyi Ding; Kai Zheng; Rajesh N Davé
Journal:  Int J Pharm       Date:  2018-12-29       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.